non-small cell lung cancer

Clovis Oncology Gets Hit Hard: FDA Delays Approval
Bidness, ETC
Mon, 11/16/15 - 09:18 am
Clovis Oncology
FDA
rociletinib
non-small cell lung cancer
Merck's Keytruda has a shot at a bigger share of NSCLC sales
Fierce Pharma Marketing
Wed, 10/28/15 - 02:59 pm
Merck
Keytruda
non-small cell lung cancer
Opdivo
Bristol-Myers Squibb
UBS analysts weigh in on FDA’s expanded approval of Merck’s Keytruda for the treatment of lung cancer
Bidness, ETC
Wed, 10/7/15 - 10:05 am
Merck
non-small cell lung cancer
FDA
Keytruda
Merck's Keytruda snags FDA approval for NSCLC, but label is narrow
Fierce Pharma
Fri, 10/2/15 - 04:57 pm
Merck
Keytruda
FDA
non-small cell lung cancer
Clovis Oncology Inc Giving AstraZeneca plc A Hard Time In Cancer
Bidness, ETC
Fri, 10/2/15 - 09:11 am
Clovis Oncology
AstraZeneca
rociletinib
AZD9291
non-small cell lung cancer
Don't be quick to peg Merck's Keytruda in second place for NSCLC, analyst says
Fierce Pharma Marketing
Mon, 09/28/15 - 10:15 am
Merck
Keytruda
non-small cell lung cancer
Bristol-Myers Squibb
Opdivo
Amgen And Allergan Announce Positive Top-line Results From Phase 3 Study of Biosimilar Candidate ABP 215
Yahoo
Wed, 09/23/15 - 09:56 am
Amgen
Allergan
ABP 215
non-small cell lung cancer
Clovis leaps as AstraZeneca's AZD9291 disappoints on lung cancer
Fierce Biotech
Thu, 09/10/15 - 05:54 pm
Clovis Oncology
AstraZeneca
AZD9291
non-small cell lung cancer
Bristol-Myers' latest PD-1 win could pave the path to earlier use
Fierce Biotech
Tue, 09/8/15 - 02:03 pm
Bristol-Myers Squibb
Opdivo
non-small cell lung cancer
Endocyte Announces Final Overall Survival Results From Phase 2b TARGET Trial in Non-Small Cell Lung Cancer Patients
Yahoo
Tue, 09/8/15 - 08:08 am
Endocyte
vintafolide
clinical trials
non-small cell lung cancer
Bristol-Myers' Opdivo snags FDA priority review for bigger lung cancer use
Fierce Pharma Marketing
Wed, 09/2/15 - 10:16 am
Opdivo
Bristol-Myers Squibb
FDA
priority review
non-small cell lung cancer
Eli Lilly's marginal cancer drug becomes Exhibit A in pricing debate
Fierce Biotech
Sat, 08/29/15 - 08:56 am
Eli Lilly
drug pricing
necitumumab
non-small cell lung cancer
After two deaths, Verastem defends safety of experimental cancer drug
Bizjournals.com
Wed, 08/26/15 - 08:43 pm
Verastem
VS-6063
non-small cell lung cancer
Hunting a fast approval in lung cancer, Roche racks up a positive PhII for 'atezo'
Fierce Biotech
Mon, 08/17/15 - 08:10 am
Roche
non-small cell lung cancer
atezolizumab
anti-PD-1 immunotherapy
FDA approves AstraZeneca's lung cancer drug as first-line treatment
Yahoo/Reuters
Mon, 07/13/15 - 05:05 pm
FDA
Iressa
AstraZeneca
non-small cell lung cancer
FDA support for Lilly cancer drug comes down to unmet needs vs side effects
BioPharma Dive
Sat, 07/11/15 - 10:34 am
FDA
Eli Lilly
necitumumab
non-small cell lung cancer
AstraZeneca Presents Positive Data on AZD9291 in First-Line EGFR Mutated Lung Cancer at ASCO 2015
Yahoo
Sun, 05/31/15 - 11:52 am
AstraZeneca
AZD9291
non-small cell lung cancer
A preview of the new lung cancer data Roche will debut at ASCO
BioPharma Dive
Fri, 05/15/15 - 09:34 am
non-small cell lung cancer
ASCO
Roche
Genentech
MPDL3280A
PDL-1 inhibitors
With Teva out, OncoGenex shrinks its PhIII lung cancer study
Fierce Biotech
Thu, 04/30/15 - 10:45 am
Teva Pharmaceutical
OncoGenex
non-small cell lung cancer
custirsen
Pfizer Receives U.S. FDA Breakthrough Therapy Designation For XALKORI® (crizotinib) For The Treatment Of Patients With ROS1-Positive Non-Small Cell Lung Cancer
Yahoo
Tue, 04/21/15 - 12:18 pm
Pfizer
Xalkori
non-small cell lung cancer
FDA

Pages